×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LEARNED SOCIETIES AND DRUG REGULATION
Session Chair(s)
Gonzalo Calvo Rojas, PhD
Consultant in Clinical Pharmacology
Hospital Clinic Barcelona, Spain
Drug development and drug assessment must be closely linked to the understanding of what the needs of patients are. The importance of setting up fora for interactions between regulators, academic associations and industry, ensuring high scientific standards and transparency will be discussed.
Speaker(s)
Regulators and Healthcare Professional Associations
Arantxa Sancho-Lopez
Hospital Puerta Hierro, Spain
Clinical Researcher
Interactions between Industry and Learned Societies
Susan Longman
Novartis Pharma AG, Switzerland
Head Regulatory Affairs Region Europe
CVCT as an Example of Interaction - is it exportable to other scientific disciplines?
Faiez Zannad, MD, PhD
Université De Lorraine, France
MD, PhD Professor
Have an account?